LuerJack in Norway – ConceptoMed AS and Vingmed AS signed a marketing, sales and distribution agreement for the hospital market

ConceptoMed AS is delighted to announce a new partner for the Norwegian hospital market.
We have entered into a distribution agreement with Vingmed AS granting exclusive rights for marketing, sales and distribution of the LuerJack syringes in the hospital market in Norway.

LuerJack Lock – US FDA 510(k) cleared

ConceptoMed AS has received FDA 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the LuerJack Slip syringes and the first LuerJack Lock 10ml syringe.

Chinese Patent issued for LuerJack

On the 14th of February 2017, the Chinese Patent and Trademark office issued an official document granting the Chinese patent for LuerJack.

ConceptoMed’s strategy to protect our intellectual property rights (IPR) remains unchanged and strong. Along with other markets already protected, such as Europe, the US, Australia and Mexico, protection in Asia is now following.

US FDA 510(k) Clearance for Luer-Jack® Slip syringe

ConceptoMed AS received FDA 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the first size of the Luer-Jack® syringe.

Luer-Jack secures Sterigenics Sterilization Services Agreement

In December 2016, ConceptoMed have entered into important collaborations with suppliers of sterilization services (Sterigenics) and logistics & healthcare warehousing services (DSV Logistics) to secure the global strategy for ConceptoMed and Luer-Jack.

Luer-Jack high-volume production agreement with AB Euroform MediPharm, Sweden

On the 28th of October 2016, ConceptoMed and AB Euroform MediPharm entered into an agreement for high-volume capacity manufacturing for Luer-Jack. Euroform MediPharm is a ISO 13485 certified long-term partner within development and production of polymer products for world class customers in Pharmaceutical and Medical Technology industries.

ConceptoMed obtains ISO 13485 certification

ConceptoMed is proud to announce that it successfully passed the ISO 13485 quality assurance audit, and was issued the international ISO 13485 certificate by SP, our Notified Body.

European and Australian Patent Issued for Luer-Jack

On the 31st of August 2016, the European Patent Office issued an official document granting the European patent for Luer-Jack.

IP Australia, the Australian Government agency that administers intellectual property (IP) rights and legislation relating to patents, issued an official document granting the Australian patent for Luer-Jack – also on the 31st of August 2016.

ConceptoMed named in Disrupt 100 – Index of Disruptive Businesses Worldwide

ConceptoMed proudly announce being named in the Disrupt 100 – a bi-annual Tällt Ventures publication celebrating the businesses with the most potential to influence, change or create new global markets. ConceptoMed were selected from over 1 million global startups and corporate ventures and judged by a selection of global brands.

US Patent issued for Luer-Jack®

On the 10th of May 2016, the United States Patent and Trademark office issued an official document granting the US patent for Luer-Jack. The US Luer-Jack patent is an important part of the families of similar filed applications in all important markets world wide, and is a fundamental member of the Luer-Jack patent family.